GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$151.90
—
Mkt Cap $5.92B
Analyst Ratings
Buy
6
Hold
4
Sell
0
Price Target (23 analysts)
$106.14
Range $56.00 – $175.00
Implied Upside
-30.1%
Consensus $106.14 vs current $151.90
NASDAQ·Healthcare·Medical - Diagnostics & Research
$151.90
—
Mkt Cap $5.92B
Buy
6
Hold
4
Sell
0
Price Target (23 analysts)
$106.14
Range $56.00 – $175.00
-30.1%
Consensus $106.14 vs current $151.90